Crimean-Congo Hemorrhagic Fever, Kosovo, 2013-2016

Insights

Crimean-Congo hemorrhagic fever (CCHF) is a serious tick-borne illness. High viral loads and organ dysfunction were observed in fatal CCHF cases, with ribavirin showing no benefit.

Area of Science:

  • Epidemiology
  • Infectious Diseases
  • Virology

Background:

  • Crimean-Congo hemorrhagic fever (CCHF) is a severe tick-borne viral disease with significant mortality.
  • Understanding prognostic indicators is crucial for managing CCHF outbreaks.

Observation:

  • A study in Prishtina, Kosovo, between 2013-2016 monitored 32 CCHF patients.
  • Eleven patients (34%) succumbed to the illness during the observation period.

Findings:

  • Fatal CCHF cases presented with extremely high viral loads ( > 1 × 10^8.5/mL).
  • Elevated lactate dehydrogenase levels ( > 2,700 U/mL) were noted in non-survivors.
  • Hemorrhagic manifestations and impaired consciousness were common in patients who died.
  • The antiviral drug ribavirin demonstrated no significant therapeutic effect in this cohort.

Implications:

  • Identifying high-risk CCHF patients early is critical for resource allocation and supportive care.
  • The limited efficacy of ribavirin suggests a need for novel therapeutic strategies against CCHF.
  • This data highlights the severe clinical course and challenges in treating CCHF in the Balkan region.